back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-25 17:22 Tx date 2022-05-25 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,350
+100 vol $313.50 each |
2,500 | |
| Filed 2022-05-20 16:19 Tx date 2022-05-20 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$686.00
+200 vol $3.43 each |
2,400 | |
| Filed 2022-05-19 14:49 Tx date 2022-05-19 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$363.50
+100 vol $3.63 each |
2,200 | |
| Filed 2022-05-19 14:48 Tx date 2022-05-18 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$388.00
+100 vol $3.88 each |
2,100 | |
| Filed 2022-05-19 14:45 Tx date 2022-05-12 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,594
+2,000 vol $3.80 each |
2,000 | |
| Filed 2022-05-12 11:51 Tx date 2022-05-12 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,594
+2,000 vol $3.80 each |
||
| Filed 2022-05-12 11:51 Tx date 2022-05-12 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,594
+2,000 vol $3.80 each |
2,000 | |
| Filed 2022-05-12 11:51 Tx date 2022-03-07 |
$ASP
Acerus Pharmaceuticals Corporation |
Herschkowitz, Samuel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-02-13 Tx date 2017-02-06 |
$PPK
Prospect Park Capital Corp. |
Herschkowitz, Samuel
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SOK Partners LLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-1,304,347 vol |
0 | |
| Filed 2017-02-13 Tx date 2017-02-06 |
$PPK
Prospect Park Capital Corp. |
Herschkowitz, Samuel
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+571,428 vol |
2,084,351 | |
| Filed 2017-02-13 Tx date 2017-02-06 |
$PPK
Prospect Park Capital Corp. |
Herschkowitz, Samuel
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+652,174 vol |
1,512,923 | |
| Filed 2016-07-25 Tx date 2016-07-20 |
$PPK
Prospect Park Capital Corp. |
Herschkowitz, Samuel
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+189,632 vol |
558,227 |